These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9247297)
1. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of TGF-alpha-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells. Baldwin RL; Kobrin MS; Tran T; Pastan I; Korc M Pancreas; 1996 Jul; 13(1):16-21. PubMed ID: 8783329 [TBL] [Abstract][Full Text] [Related]
3. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Damstrup L; Kuwada SK; Dempsey PJ; Brown CL; Hawkey CJ; Poulsen HS; Wiley HS; Coffey RJ Br J Cancer; 1999 Jun; 80(7):1012-9. PubMed ID: 10362109 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells. Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525 [TBL] [Abstract][Full Text] [Related]
5. Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line. Normanno N; Selvam MP; Bianco C; Damiano V; de Angelis E; Grassi M; Magliulo G; Tortora G; Salomon DS; Ciardiello F Int J Cancer; 1995 Sep; 62(6):762-6. PubMed ID: 7558427 [TBL] [Abstract][Full Text] [Related]
6. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. Johnson GR; Saeki T; Gordon AW; Shoyab M; Salomon DS; Stromberg K J Cell Biol; 1992 Aug; 118(3):741-51. PubMed ID: 1639855 [TBL] [Abstract][Full Text] [Related]
7. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Normanno N; Selvam MP; Qi CF; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2790-4. PubMed ID: 7908443 [TBL] [Abstract][Full Text] [Related]
8. Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family. Culouscou JM; Remacle-Bonnet M; Carlton GW; Plowman GD; Shoyab M Growth Factors; 1992; 7(3):195-205. PubMed ID: 1333777 [TBL] [Abstract][Full Text] [Related]
9. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. De Luca A; Selvam MP; Sandomenico C; Pepe S; Bianco AR; Ciardiello F; Salomon DS; Normanno N Int J Cancer; 1997 Oct; 73(2):277-82. PubMed ID: 9335455 [TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. Wagner M; Weber CK; Bressau F; Greten FR; Stagge V; Ebert M; Leach SD; Adler G; Schmid RM Gastroenterology; 2002 Jun; 122(7):1898-912. PubMed ID: 12055597 [TBL] [Abstract][Full Text] [Related]
11. EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells. Casamassimi A; De Luca A; Agrawal S; Stromberg K; Salomon DS; Normanno N Ann Oncol; 2000 Mar; 11(3):319-25. PubMed ID: 10811499 [TBL] [Abstract][Full Text] [Related]
12. The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion. Thorne BA; Plowman GD Mol Cell Biol; 1994 Mar; 14(3):1635-46. PubMed ID: 8114701 [TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa. Abe S; Sasano H; Katoh K; Ohara S; Arikawa T; Noguchi T; Asaki S; Yasui W; Tahara E; Nagura H; Toyota T Dig Dis Sci; 1997 Jun; 42(6):1199-209. PubMed ID: 9201085 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Ciardiello F; Kim N; Saeki T; Dono R; Persico MG; Plowman GD; Garrigues J; Radke S; Todaro GJ; Salomon DS Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7792-6. PubMed ID: 1715580 [TBL] [Abstract][Full Text] [Related]
16. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. Wong L; Deb TB; Thompson SA; Wells A; Johnson GR J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134 [TBL] [Abstract][Full Text] [Related]
17. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Kondapaka SB; Fridman R; Reddy KB Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655 [TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Mishima K; Higashiyama S; Asai A; Yamaoka K; Nagashima Y; Taniguchi N; Kitanaka C; Kirino T; Kuchino Y Acta Neuropathol; 1998 Oct; 96(4):322-8. PubMed ID: 9796995 [TBL] [Abstract][Full Text] [Related]
20. Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Rodrigues S; Attoub S; Nguyen QD; Bruyneel E; Rodrigue CM; Westley BR; May FE; Thim L; Mareel M; Emami S; Gespach C Oncogene; 2003 Jul; 22(29):4488-97. PubMed ID: 12881705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]